Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Turoctocog alfa - Novo Nordisk

Next Previous
X
Search
Drug Profile

Turoctocog alfa - Novo Nordisk

Alternative Names: N8; NN-7008; NNC-0155-0000-0004; NovoEight; Recombinant factor VIII - Novo Nordisk; rFVIII - Novo Nordisk; Zonovate

Latest Information Update: 05 Nov 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Novo Nordisk
  • Class Antihaemorrhagics; Blood coagulation factors; Recombinant proteins
  • Mechanism of Action Blood coagulation factor replacements; Factor X stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Haemophilia A

Most Recent Events

  • 01 Dec 2022 No development reported - Phase-III for Haemophilia A (In adolescents, In children, Treatment-experienced, In adults) in Germany, Bulgaria, United Kingdom (SC)
  • 01 Dec 2022 No development reported - Phase-III for Haemophilia A (In children, Treatment-naive) in United Kingdom, Portugal, Poland, Lithuania, Hungary (IV)
  • 07 Jul 2020 Novo Nordisk terminates a phase III trial for Haemophilia A (In adolescents, In children, Treatment-experienced, In adults, In the elderly) in Austria, Bulgaria, France, Germany, Serbia, Turkey, United Kingdom (SC) as the participant withdrew from the trial (NCT03588741)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top